Discover 1,438 paid clinical trials in Bradenton, Florida. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,438
Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab
for
Atopic Dermatitis
Location: Saint Petersburg FL, Orange City FL,
Sponsor: ASLAN Pharmaceuticals
Sex: All
Age: 18+
Code: NCT05694884
Phase2, Recruiting
A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration
for
Geographic Atrophy
Location: St. Petersburg FL, Gainesville FL, Ladson SC,
Sponsor: Sanofi
Sex: All
Age: 60+
Code: NCT07215234
Phase1, Phase2, Recruiting
PEN-866 in Patients With Advanced Solid Malignancies
for
Carcinoma, Endometrial Adenocarcinoma, Neoplasms,
Location: Saint Petersburg FL, Fort Myers FL, West Palm Beach FL,
Sponsor: Tarveda Therapeutics
Sex: All
Age: 18+
Code: NCT03221400
Phase1, Phase2, Recruiting
A Study to Investigate Efficacy and Safety of Teplizumab Compared With Placebo in Participants 1 to 25 Years of Age With Stage 3 Type 1 Diabetes
for
Type 1 Diabetes Mellitus
Location: Tampa FL, Winter Park FL, Gainesville FL, Hollywood FL,
Sponsor: Sanofi
Sex: All
Age: 1 - 25
Code: NCT07088068
Phase3, Recruiting
Sublingual Buprenorphine Treatment for Neonatal Abstinence Syndrome - Pilot Study
for
Drug; Withdrawal Symptoms, Neonatal, Withdrawal,
Location: St Petersburg FL
Sponsor: Gauda, Estelle B., M.D.
Sex: All
Age: 0
Code: NCT02249026
Phase1, Phase2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Phase 3 Study of Rezpegaldesleukin (NKTR-358) for Patients ≥ 12 Years of Age With Moderate-to-Severe Atopic Dermatitis
for
Moderate-to-Severe Atopic Dermatitis
Location: St. Petersburg FL, Tampa FL, Boca Raton FL, Macon GA,
Sponsor: Nektar Therapeutics
Sex: All
Age: 12+
Code: NCT07690371
Phase3, Recruiting
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)
Location: St. Petersburg FL, Tampa FL, Lakeland FL, Fort Myers FL,
Sponsor: Adverum Biotechnologies, Inc.
Sex: All
Age: 50+
Code: NCT07482176
Phase3, Recruiting
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
for
Geographic Atrophy (GA),
Location: Sarasota FL, Tampa FL, Orlando FL, Pensacola FL,
Sponsor: ONL Therapeutics
Sex: All
Age: 55+
Code: NCT06659445
Phase2, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Sarasota FL, Tampa FL, Orlando FL,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190222
Phase3, Recruiting
Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica
for
Polymyalgia Rheumatica
Location: Sarasota FL, Tampa FL, Clearwater FL, DeBary FL,
Sponsor: Sanofi
Sex: All
Age: 50+
Code: NCT07286214
Recruiting
RCT of the Jewish Family & Children's Services (JFCS) HFHC Program
for
Family Relations
Location: Sarasota FL
Sponsor: Jewish Family & Children's Service of the Suncoast, Inc.
Sex: All
Age: 18 - 64
Code: NCT02853825
Recruiting
A First-in-Human Study of MEN2501 in Participants With Platinum-Resistant Ovarian Cancer
for
Platinum-resistant Ovarian Cancer
Location: Sarasota FL, Fairfax VA, Springdale AR, Detroit MI,
Sponsor: Stemline Therapeutics, Inc.
Sex: Female
Age: 18+
Code: NCT07226427
Phase1, Recruiting
Study of ACR-2316 in Specific Advanced Solid Tumors
for
Specific Advanced Solid Tumors
Location: Sarasota FL, Huntersville NC, Franklin TN, Houston TX,
Sponsor: Acrivon Therapeutics
Sex: All
Age: 18+
Code: NCT06667141
Phase1, Phase2, Recruiting
A Study of MF101 in Postmenopausal Women
for
Hot Flushes, Vasomotor Symptoms
Location: Bradenton FL, St. Petersburg FL, Tampa FL,
Sponsor: Bionovo
Sex: Female
Age: 40 - 65
Code: NCT00906308
Phase3, Recruiting
A Study to Test the Efficacy and Safety of Riliprubart Against the Usual Treatment of Intravenous Immunoglobulin (IVIg) in People With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
for
Chronic Inflammatory Demyelinating Polyneuropathy
Location: Bradenton FL, Orlando FL, Homewood AL, New Orleans LA,
Sponsor: Sanofi
Sex: All
Age: 18+
Code: NCT06290141
Phase3, Recruiting
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
for
Metabolic Dysfunction-associated Steatohepatitis
Location: Bradenton FL, Ocala FL, Viera FL, Port Orange FL,
Sponsor: Eccogene
Sex: All
Age: 18 - 70+
Code: NCT07288138
Phase2, Recruiting
Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis
for
Non Alcoholic Steatohepatitis (NASH)
Location: Bradenton FL, Pinellas Park FL, Clearwater FL, Ocoee FL,
Sponsor: Axcella Health, Inc
Sex: All
Age: 18+
Code: NCT04880187
Phase2, Recruiting
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
for
Heart Failure
Location: Bradenton FL, Miramar FL, Fort Lauderdale FL,
Sponsor: Colorado Prevention Center
Sex: All
Age: 18+
Code: NCT06024746
Phase3, Recruiting
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists